BIS Research Study Highlights the Global Digital Polymerase Chain Reaction (d-PCR) Market to Reach $585.8 million by 2025

The Global Digital Polymerase Chain Reaction (d-PCR) Market is projected to reach $585.8 million by 2025, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 17.57% during the period between 2020 and 2025.

View the Report from BIS Research at https://bisresearch.com/industry-report/digital-pcr-market.html

The comprehensive study of global nucleic acid isolation and purification BIS Research extensively covers the following:

• Market numbers on micro-segments that are influencing the market
• More than 300 products present in the market
• Market share analysis for more than 15 companies
• End-user preference data for over 20 end users
• Detailed global and regional market share analysis including the scrutiny of more than 15 countries
• Study of data of more than 15 companies

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 400+ products.

Request for a Sample: https://bisresearch.com/requestsample?id=849&type=download

BIS Research study indicates that the increasing number of genetic tests taken, the growing demand for reliable gene expression results, the rising prevalence of infectious diseases, and the improving funding scenario in the field of microbiology, among others, are fueling the growth of the market.

The market intelligence by BIS Research additionally throws a spotlight on the key industry trends that have a humungous influence in shaping the industry going forward. Some of these trends include the emergence of chip-based digital PCR, focus on digitization of patient data, novel targets for isolation and purification, exploration of new applications, and several other key trends.

To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include end user and pricing analysis, types of products offered, type of digital PCR, application, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.

The end user and pricing analysis of the global market includes data analysis on the satisfaction level of different instruments (by brand), pricing analysis of preferred instruments, accessories & components, and consumables. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as consumables and instruments. The consumables are further categorized into kits and reagents.

To emphasize the dominance of the consumable segment over the instruments segment under the product category of digital PCR in 2020 and 2025, Nitish Kumar Singh, Lead Analyst – BIS Research, states, "The reason for market growth and the dominance consumable segment can be attributed to the prevalent product type and its widespread use in almost all clinical application as well as in environment monitoring and food and agriculture. It is anticipated that the consistent growth in the utilization of accessories, kits and reagents will be another reason for the segment to witness a significant growth in the coming years.”

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The key players profiled in the report include , Thermo Fisher Scientific, Bio-Rad Laboratories, Inc.., Optolane Technologies, Inc., Qiagen NV, Stem Genomics, Fluidigm Corporation, Merck KGaA, JN Medsys, QIAGEN N.V., Stilla Technologies, Dropworks, Inc. Naveris, Inc. Genetron Holdings Limited among others
The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

Who should buy this report?

• Manufacturers of digital PCR-based instruments, kits, assays, and consumables
• Companies involved in drug manufacturing
• Companies in services market of Digital PCR

How can market intelligence on digital PCR add value to an organization’s decision-making process?
• Aid in product development
• Help in targeting a segment for launching a new product
• Offer detailed information on the future perspective of the emerging as well as established players
• Offer go-to market strategies for the different source type
• Support in diversifying the product portfolio basis risk and progression of technology (DNA, RNA, and Analyte)
• Help in analyzing technological substitutes and compare the specification
• Offer tailor-made solutions based on the throughput of different consumers
• Aid in understanding the end-user requirement
• Assist in exploring the newer application
• Support in analyzing the competitors’ funding scenario
• Aid in understanding the new trends in the industry

Insightful Questions Covered to Enable Companies take Strategic Decisions

 What are the major market drivers, challenges, and opportunities in the global digital PCR market?
 What is the potential impact of biotechnological advancement in diagnostic industry among the end users, such as researchers, physicians, and laboratory technicians?
 What is the current market demand along with future expected demand of global digital PCR market?
 How has digital PCR helped genomic tests to become a prominent tool for diagnostics in various clinical applications?
 What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
 How each segment of the market is expected to grow during the forecast period from 2020 to 2025 based on:
o Product Type
o Clinical Area
o End user
o Region: Region includes North America, Europe, Asia-Pacific, Rest-of-the-World (ROW)?
 Who are the leading players with significant offerings to the global digital PCR (d-PCR) market? What is the expected market dominance for each of these leading players?
 Which companies are anticipated to be highly disruptive in the future, and why?

BIS Research Related Market Studies:

https://bisresearch.com/industry-report/global-next-generation-sequencing-market-2024.html

https://bisresearch.com/industry-report/rare-disease-diagnostics-market.html

Contact:

Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.

Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

BIS Research offers syndicate as well as, custom studies, and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.

BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.

This release was published on openPR.